Nexalin Technology (NXL) FCF Margin (2021 - 2026)
Nexalin Technology (NXL) posted quarterly FCF Margin of 11787.72% for Q1 2026, down 831042.0% year-over-year from N/an in Q1 2025, and down 1664.99% quarter-over-quarter from 667.86% in Q4 2025.
Nexalin Technology (NXL) FCF Margin (2021 - 2026) Analysis & Trends
Nexalin Technology's FCF Margin history runs 6 years deep, the most recent figure standing at 11787.72% for Q1 2026.
- In Q1 2026, FCF Margin fell 831042.0% year-over-year to 11787.72%; the TTM figure through Mar 2026 stood at 1920.92% (up 159437.0% YoY), while the FY2025 annual figure was 1643.53%, up 69429.0% from the prior year.
- FCF Margin for Q1 2026 stood at 11787.72%, down from 667.86% in the prior quarter.
- The five-year high for FCF Margin was 39.17% in Q2 2022, with the low at 11787.72% in Q1 2026.
- The 5-year median for FCF Margin is 2359.09% (2022), against an average of 3196.93%.
- The sharpest annual moves came in 2025 and 2026: FCF Margin jumped 350623 bps in 2025, then plunged 831042 bps in 2026.
- Nexalin Technology's FCF Margin stood at 2359.09% in 2022, then tumbled by 107 bps to 4889.12% in 2023, then advanced by 15 bps to 4174.09% in 2024, then surged by 84 bps to 667.86% in 2025, then plunged by 1665 bps to 11787.72% in 2026.
- Business Quant data shows NXL's FCF Margin at 11787.72% in Q1 2026, 667.86% in Q4 2025, and 8079.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 18.73% |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 | -14,814.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14,814.80% |
| Mar 31, 2026 | -11,787.72% |
| Dec 31, 2025 | -667.86% |
| Sep 30, 2025 | -8,079.00% |
| Jun 30, 2025 | -1,299.32% |
| Mar 31, 2025 | -3,477.30% |
| Dec 31, 2024 | -4,174.09% |
| Sep 30, 2024 | -2,220.89% |
| Jun 30, 2024 | -4,643.87% |
| Mar 31, 2024 | -970.23% |
| Dec 31, 2023 | -4,889.12% |
| Sep 30, 2023 | -2,907.54% |
| Jun 30, 2023 | -2,294.91% |
| Mar 31, 2023 | -4,301.86% |
| Dec 31, 2022 | -2,359.09% |
| Sep 30, 2022 | -173.05% |
| Jun 30, 2022 | -39.17% |
| Mar 31, 2022 | -62.87% |
| Dec 31, 2021 | -1,704.62% |